{"title":"核富集常染色体转录物1的过表达通过靶向MicroRNA-202-3p/T细胞免疫球蛋白和粘蛋白结构域4轴促进子宫内膜癌细胞增殖、迁移侵袭和抑制凋亡","authors":"Caiyan Xu, Jianjun Zhai, Yujing Fu","doi":"10.1089/cbr.2020.3902","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Endometrial cancer (EC) is an intractable gynecological cancer with increasing incidence and mortality worldwide. Accumulating studies indicated that long noncoding RNA nuclear enriched autosomal transcript 1 (<i>NEAT1</i>) was a novel oncogene implicated in a variety of cancers. However, whether <i>NEAT1</i> could accelerate cell growth in EC is unclear. <b><i>Materials and Methods:</i></b> <i>NEAT1</i>, microRNA (miR)-202-3p, and T cell immunoglobulin and mucin domain 4 (<i>TIMD4</i>) levels were detected by quantitative real-time polymerase chain reaction. Cell proliferation and apoptosis were examined by cell counting kit-8 and flow cytometry. Transwell assay was employed for the evaluation of cell migration and invasion. The relationship between miR-202-3p and <i>NEAT1</i> or <i>TIMD4</i> was determined by luciferase reporter system. TIMD4 protein expression was assessed by Western blot assay. <b><i>Results:</i></b> <i>NEAT1</i> was upregulated, whereas miR-202-3p was downregulated in EC tumors and cells. Depletion of <i>NEAT1</i> restrained EC cell proliferation, migration, invasion, and improved apoptosis. MiR-202-3p was targeted by <i>NEAT1</i> and could bind to <i>TIMD4</i>. Subsequently, it is observed that miR-202-3p inhibitor neutralized NEAT1 silencing mediated suppression on EC cell progression. Meanwhile, TIMD4 rescued miR-202-3p induced inhibition on cell progression in EC. Furthermore, it was obvious that <i>NEAT1</i> facilitated TIMD4 expression by absorbing miR-202-3p in EC. <b><i>Conclusions:</i></b> Upregulation of NEAT1 accelerated EC cell progression through sponging miR-202-3p to facilitate TIMD4 expression, providing potential novel treatment method for EC.</p>","PeriodicalId":518937,"journal":{"name":"Cancer biotherapy & radiopharmaceuticals","volume":" ","pages":"815-823"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/cbr.2020.3902","citationCount":"6","resultStr":"{\"title\":\"Overexpression of Nuclear Enriched Autosomal Transcript 1 Facilitates Cell Proliferation, Migration Invasion, and Suppresses Apoptosis in Endometrial Cancer by Targeting MicroRNA-202-3p/T Cell Immunoglobulin and Mucin Domain 4 Axis.\",\"authors\":\"Caiyan Xu, Jianjun Zhai, Yujing Fu\",\"doi\":\"10.1089/cbr.2020.3902\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Endometrial cancer (EC) is an intractable gynecological cancer with increasing incidence and mortality worldwide. Accumulating studies indicated that long noncoding RNA nuclear enriched autosomal transcript 1 (<i>NEAT1</i>) was a novel oncogene implicated in a variety of cancers. However, whether <i>NEAT1</i> could accelerate cell growth in EC is unclear. <b><i>Materials and Methods:</i></b> <i>NEAT1</i>, microRNA (miR)-202-3p, and T cell immunoglobulin and mucin domain 4 (<i>TIMD4</i>) levels were detected by quantitative real-time polymerase chain reaction. Cell proliferation and apoptosis were examined by cell counting kit-8 and flow cytometry. Transwell assay was employed for the evaluation of cell migration and invasion. The relationship between miR-202-3p and <i>NEAT1</i> or <i>TIMD4</i> was determined by luciferase reporter system. TIMD4 protein expression was assessed by Western blot assay. <b><i>Results:</i></b> <i>NEAT1</i> was upregulated, whereas miR-202-3p was downregulated in EC tumors and cells. Depletion of <i>NEAT1</i> restrained EC cell proliferation, migration, invasion, and improved apoptosis. MiR-202-3p was targeted by <i>NEAT1</i> and could bind to <i>TIMD4</i>. Subsequently, it is observed that miR-202-3p inhibitor neutralized NEAT1 silencing mediated suppression on EC cell progression. Meanwhile, TIMD4 rescued miR-202-3p induced inhibition on cell progression in EC. Furthermore, it was obvious that <i>NEAT1</i> facilitated TIMD4 expression by absorbing miR-202-3p in EC. <b><i>Conclusions:</i></b> Upregulation of NEAT1 accelerated EC cell progression through sponging miR-202-3p to facilitate TIMD4 expression, providing potential novel treatment method for EC.</p>\",\"PeriodicalId\":518937,\"journal\":{\"name\":\"Cancer biotherapy & radiopharmaceuticals\",\"volume\":\" \",\"pages\":\"815-823\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1089/cbr.2020.3902\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer biotherapy & radiopharmaceuticals\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1089/cbr.2020.3902\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/9/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer biotherapy & radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/cbr.2020.3902","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Overexpression of Nuclear Enriched Autosomal Transcript 1 Facilitates Cell Proliferation, Migration Invasion, and Suppresses Apoptosis in Endometrial Cancer by Targeting MicroRNA-202-3p/T Cell Immunoglobulin and Mucin Domain 4 Axis.
Background: Endometrial cancer (EC) is an intractable gynecological cancer with increasing incidence and mortality worldwide. Accumulating studies indicated that long noncoding RNA nuclear enriched autosomal transcript 1 (NEAT1) was a novel oncogene implicated in a variety of cancers. However, whether NEAT1 could accelerate cell growth in EC is unclear. Materials and Methods:NEAT1, microRNA (miR)-202-3p, and T cell immunoglobulin and mucin domain 4 (TIMD4) levels were detected by quantitative real-time polymerase chain reaction. Cell proliferation and apoptosis were examined by cell counting kit-8 and flow cytometry. Transwell assay was employed for the evaluation of cell migration and invasion. The relationship between miR-202-3p and NEAT1 or TIMD4 was determined by luciferase reporter system. TIMD4 protein expression was assessed by Western blot assay. Results:NEAT1 was upregulated, whereas miR-202-3p was downregulated in EC tumors and cells. Depletion of NEAT1 restrained EC cell proliferation, migration, invasion, and improved apoptosis. MiR-202-3p was targeted by NEAT1 and could bind to TIMD4. Subsequently, it is observed that miR-202-3p inhibitor neutralized NEAT1 silencing mediated suppression on EC cell progression. Meanwhile, TIMD4 rescued miR-202-3p induced inhibition on cell progression in EC. Furthermore, it was obvious that NEAT1 facilitated TIMD4 expression by absorbing miR-202-3p in EC. Conclusions: Upregulation of NEAT1 accelerated EC cell progression through sponging miR-202-3p to facilitate TIMD4 expression, providing potential novel treatment method for EC.